NCT05286034 Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme
| NCT ID | NCT05286034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | International Agency for Research on Cancer |
| Condition | Cervical Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2025-11-03 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,000 participants in total. It began in 2025-11-03 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project looks to improve the return rate of HPV self-sampling (HPVss) as well as the management of women HPVss positive.
Eligibility Criteria
Inclusion criteria: eligible women will be: * aged 30-65 * did not perform a pap smear in the last 4 years * are living in deprived clusters in the Occitanie region. * did not answer to a first "invitation" letter to perform a clinician-collected HPV testing Exclusion criteria: ineligible women will be those: * outside the target age group * had a Pap smear in the past 3 years * had hysterectomy including cervix * are pregnant * already scheduled a screening appointment or had just attended a HPV screening * had a cervical abnormality that was under exploration and/or treatment. * participated to the study pilot
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05286034 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 65 Years, studying Cervical Cancer Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05286034 currently recruiting?
Yes, NCT05286034 is actively recruiting participants. Contact the research team at selmounif@iarc.who.int for enrollment information.
Where is the NCT05286034 trial being conducted?
This trial is being conducted at Carcassone, France.
Who is sponsoring the NCT05286034 clinical trial?
NCT05286034 is sponsored by International Agency for Research on Cancer. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.